Paul Bunn Selected Research

Necrosis

8/2004

Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Bunn Research Topics

Disease

8	Neoplasms (Cancer) 01/2020 - 04/2002
5	Lung Neoplasms (Lung Cancer) 01/2020 - 04/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 07/2004
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Hearing Loss (Hearing Impairment) 02/2014
1	Breast Neoplasms (Breast Cancer) 07/2009
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2009
1	Melanoma (Melanoma, Malignant) 01/2009
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2006
1	Neutropenia 05/2006
1	Necrosis 08/2004
1	Thrombosis (Thrombus) 08/2004
1	Disease Progression 07/2004
1	Mesothelioma 07/2004

Drug/Important Bio-Agent (IBA)

2	Cisplatin (Platino)FDA LinkGeneric 05/2006 - 07/2004
1	RNA (Ribonucleic Acid)IBA 01/2020
1	VaccinesIBA 01/2009
1	AntigensIBA 01/2009
1	Carboplatin (JM8)FDA LinkGeneric 05/2006
1	Docetaxel (Taxotere)FDA Link 05/2006
1	Pharmaceutical PreparationsIBA 05/2006
1	Etoposide (VP 16)FDA LinkGeneric 05/2006
1	Gefitinib (Iressa)FDA Link 08/2004
1	Tyrosine Kinase InhibitorsIBA 08/2004
1	Monoclonal AntibodiesIBA 08/2004
1	N-acetylcochinol-O-phosphateIBA 08/2004
1	von Willebrand FactorIBA 08/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2004
1	ErbB Receptors (EGF Receptor)IBA 08/2004
1	Pemetrexed (MTA)FDA Link 07/2004
1	Drug CombinationsIBA 07/2004
1	Cytotoxins (Cytolysins)IBA 07/2004
1	AntimetabolitesIBA 07/2004
1	Gemcitabine FDA Link 07/2004
1	CU201IBA 04/2002
1	Bradykinin Receptor AntagonistsIBA 04/2002
1	NeuropeptidesIBA 04/2002
1	Cell Surface ReceptorsIBA 04/2002
1	BradykininIBA 04/2002
1	Substance PIBA 04/2002

Therapy/Procedure

4	Therapeutics 01/2020 - 04/2002
1	Neoadjuvant Therapy 01/2020
1	Immunotherapy 01/2015
1	Hearing Aids (Hearing Aid) 02/2014
1	Drug Therapy (Chemotherapy) 07/2009
1	Chemoradiotherapy 05/2006
1	Radiotherapy 08/2004